Protective effects of L-arginine against ischemia-reperfusion injury in non-heart beating rat liver graft

Hepatobiliary and Pancreatic Diseases International

Volumn 7, Issue 5, 2008, Pages 481-484

  Gong, Jin ^a   Lao, Xue Jun ^a   Zhang, Shui Jun ^b   Chen, Shi ^c  

^a JINAN UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Ischemia reperfusion injury; L arginine; Liver transplantation; Nitric oxide; Non heart beating donor

Indexed keywords

ALANINE AMINOTRANSFERASE; ARGININE; ASPARTATE AMINOTRANSFERASE; ENDOTHELIN; NITRIC OXIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CADAVER DONOR; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; LIVER GRAFT; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; WISTAR RAT;

ALANINE TRANSAMINASE; ANIMALS; ARGININE; ASPARTATE AMINOTRANSFERASES; DISEASE MODELS, ANIMAL; ENDOTHELINS; FEMALE; INJECTIONS, INTRAVENOUS; LIVER; LIVER TRANSPLANTATION; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NITRIC OXIDE; ORGAN PRESERVATION; PROTECTIVE AGENTS; RATS; RATS, WISTAR; REPERFUSION INJURY; TIME FACTORS; WARM ISCHEMIA;

EID: 55049115454     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Zheng SS, Shi QF, Liang TB, Wu J, Wang WL, Shen Y, et al. Orthotopic liver transplantation for patients with Klatskin tumor. Hepatobiliary Pancreat Dis Int 2005;4:28-31.
2. Rojas A, Chen L, Bartlett RH, Arenas JD. Assessment of liver function during extracorporeal membrane oxygenation in the non-heart beating donor swine. Transplant Proc 2004; 36:1268-1270.
3. Arias-Diaz J, Alvarez J, del Barrio MR, Balibrea JL. Non-heart-beating donation: current state of the art. Transplant Proc 2004;36:1891-1893.
4. Iwane T, Akamatsu Y, Narita T, Nakamura A, Satomi S. The effect of perfusion prior to cold preservation and addition of biliverdin on the liver graft from non-heart-beating donors. Transplant Proc 2006;38:3358-3361.
5. Kamada N, Calne RY. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 1983; 93:64-69.
6. Kashfi A, Mehrabi A, Pahlavan PS, Schemmer P, Gutt CN, Friess H, et al. A review of various techniques of orthotopic liver transplantation in the rat. Transplant Proc 2005; 37:185-188.
7. Kaczmarek B, Manas MD, Jaques BC, Talbot D. Ischemic cholangiopathy after liver transplantation from controlled non-heart-beating donors-a single-center experience. Transplant Proc 2007;39:2793-2795.
8. Bessems M, Doorschodt BM, van Marle J, Vreeling H, Meijer AJ, van Gulik TM. Improved machine perfusion preservation of the non-heart-beating donor rat liver using Polysol: a new machine perfusion preservation solution. Liver Transpl 2005;11:1379-1388.
9. Centurion SA, Centurion LM, Souza ME, Gomes MC, Sankarankutty AK, Mente ED, et al. Effects of ischemic liver preconditioning on hepatic ischemia/ reperfusion injury in the rat. Transplant Proc 2007;39:361-364.
10. Kume M, Banafsche R, Yamamoto Y, Yamaoka Y, Nobiling R, Gebhard MM, et al. Dynamic changes of post-ischemic hepatic microcirculation improved by a pre-treatment of phosphodiesterase-3 inhibitor, milrinone. J Surg Res 2006; 136:209-218.
11. Yuan GJ, Ma JC, Gong ZJ, Sun XM, Zheng SH, Li X. Modulation of liver oxidant-antioxidant system by ischemic preconditioning during ischemia/ reperfusion injury in rats. World J Gastroenterol 2005;11:1825-1828.
12. Zhang SJ, Shi JH, Tang Z, Wu Y, Chen S. Protective effects of glycine pretreatment on brain-death donor liver. Hepatobiliary Pancreat Dis Int 2005;4:37-40.
13. Terluk M, Cunha Da Silva E, Antunes T, Assreuy J. The presence of the endothelial layer reduces nitric oxide-induced hyporesponsiveness to phenylephrine in rat aorta. Endothelium 2004;11:181-187.
14. Gonon AT, Erbas D, Broijersén A, Valen G, Pernow J. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2004;286:H1767-1774.
15. Jeong GY, Chung KY, Lee WJ, Kim YS, Sung SM. The effect of a nitric oxide donor on endogenous endothelin-1 expression in renal ischemia/ reperfusion injury. Transplant Proc 2004;36:1943-1945.
16. Koeppel TA, Mihaljevic N, Kraenzlin B, Loehr M, Jesenofsky R, Post S, et al. Enhanced iNOS gene expression in the steatotic rat liver after normothermic ischemia. Eur Surg Res 2007;39:303-311.
17. Fernández N, Martínez MA, Climent B, García-Villalón AL, Monge L, Sanz E, et al. In vivo coronary effects of endothelin-1 after ischemia-reperfusion. Role of nitric oxide and prostanoids. Eur J Pharmacol 2003;481:109-117.
18. Kukreja RC. Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase. Br J Pharmacol 2007;150:538-540.
19. Symons JD, Hayashi Y, Ensunsa JL. Improved coronary vascular function evoked by high-intensity treadmill training is maintained in arteries exposed to ischemia and reperfusion. J Appl Physiol 2003;95:1638-1647.